Intravenous Tranexamic Acid

NANot yet recruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

February 15, 2026

Study Completion Date

March 30, 2026

Conditions
Obese PatientsObese Patients With Bariatric SurgeryBleeding
Interventions
DRUG

After induction of anaesthesia tranexamic acid will be administered at the start of surgery to reduce intraoperative bleeding. loading dose of 10 mg/kg for high BMI patients who are undergoing bariatr

This intervention will be applied for High-risk patients, with obesity, BMI more than 45, Preexisting cardiovascular condition, Hypertension, diabetes, or coagulation disorders, thyroid dysfunction and pulmonary disorders.

Trial Locations (1)

6539307

King Salman Specialist Hospital, Hail, KSA, Hail

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT07192640 - Intravenous Tranexamic Acid | Biotech Hunter | Biotech Hunter